Abbott Laboratories (ABT)
109.00
-1.36
(-1.23%)
USD |
NYSE |
Sep 01, 15:21
Abbott Laboratories Research and Development Expense (Annual) : 2.889B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 2.889B |
| December 31, 2024 | 2.823B |
| December 31, 2023 | 2.719B |
| December 31, 2022 | 2.852B |
| December 31, 2021 | 2.738B |
| December 31, 2020 | 2.418B |
| December 31, 2019 | 2.408B |
| December 31, 2018 | 2.288B |
| December 31, 2017 | 2.13B |
| December 31, 2016 | 1.358B |
| December 31, 2015 | 1.369B |
| December 31, 2014 | 1.286B |
| December 31, 2013 | 1.371B |
| December 31, 2012 | 1.544B |
| December 31, 2011 | 4.060B |
| December 31, 2010 | 3.572B |
| December 31, 2009 | 2.744B |
| December 31, 2008 | 2.689B |
| December 31, 2007 | 2.403B |
| December 31, 2006 | 2.226B |
| December 31, 2005 | 1.811B |
| December 31, 2004 | 1.697B |
| December 31, 2003 | 1.733B |
| Date | Value |
|---|---|
| December 31, 2002 | 1.562B |
| December 31, 2001 | 1.575B |
| December 31, 2000 | 1.351B |
| December 31, 1999 | 1.194B |
| December 31, 1998 | 1.222B |
| December 31, 1997 | 1.302B |
| December 31, 1996 | 1.205B |
| December 31, 1995 | 1.073B |
| December 31, 1994 | 963.52M |
| December 31, 1993 | 880.97M |
| December 31, 1992 | 772.41M |
| December 31, 1991 | 666.34M |
| December 31, 1990 | 567.01M |
| December 31, 1989 | 501.77M |
| December 31, 1988 | 454.64M |
| December 31, 1987 | 361.34M |
| December 31, 1986 | 284.89M |
| December 31, 1985 | 240.58M |
| December 31, 1984 | 218.71M |
| December 31, 1983 | 184.53M |
| December 31, 1982 | 136.97M |
| December 31, 1981 | 113.66M |
| December 31, 1980 | 97.56M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Becton, Dickinson & Co. | 1.265B |
| Boston Scientific Corp. | 2.052B |
| DexCom, Inc. | 594.90M |
| Insulet Corp. | 301.10M |
| Intuitive Surgical, Inc. | 1.312B |